Recent advances in cellular therapy for malignant lymphoma.
作者： Junji Tanaka
DOI: 10.1016/J.JCYT.2020.12.007
关键词:
摘要: Cellular therapies for malignant lymphoma include autologous or allogeneic hematopoietic stem cell transplantation (HSCT) and adaptive cellular therapy using EBV-specific T cells, cytokine-induced killer (CIK) NKT NK chimeric antigen receptor (CAR-T) cells (CAR-NK) cells. In this review we discusses recent advances of these consider ways to optimize therapies. Not only a single strategy one therapies, but also multi-disciplinary treatment combines with antibodies, such as an anti-tumor antibody immune checkpoint antibody, may be more effective relapsed refractory lymphoma.
isct-cytotherapy.org参考文章(88)
Robert Chen, Joycelynne M. Palmer, Peter Martin, Nicole Tsai, Young Kim, Bihong T. Chen, Leslie Popplewell, Tanya Siddiqi, Sandra H. Thomas, Michelle Mott, Firoozeh Sahebi, Saro Armenian, John Leonard, Auayporn Nademanee, Stephen J. Forman, Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma Biology of Blood and Marrow Transplantation. ,vol. 21, pp. 2136- 2140 ,(2015) , 10.1016/J.BBMT.2015.07.018
Wei Wang, Amy K Erbe, Jacquelyn A Hank, Zachary S Morris, Paul M Sondel, NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy. Frontiers in Immunology. ,vol. 6, pp. 368- 368 ,(2015) , 10.3389/FIMMU.2015.00368
Seok-Goo Cho, Nayoun Kim, Hyun-Jung Sohn, Suk Kyeong Lee, Sang Taek Oh, Hyun-Joo Lee, Hyun-Il Cho, Hyeon Woo Yim, Seung Eun Jung, Gyeongsin Park, Joo Hyun Oh, Byung-Ock Choi, Sung Won Kim, Soo Whan Kim, Nak Gyun Chung, Jong Wook Lee, Young Seon Hong, Tai-Gyu Kim, Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs. Molecular Therapy. ,vol. 23, pp. 1401- 1409 ,(2015) , 10.1038/MT.2015.91
Bo Yang, Xue-chun Lu, Rui-li Yu, Xiao-hua Chi, Yang Liu, Yao Wang, Han-ren Dai, Hong-li Zhu, Li-li Cai, Wei-dong Han, Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial. Hematological Oncology. ,vol. 30, pp. 115- 122 ,(2012) , 10.1002/HON.1012
Aradhana Awasthi, Janet Ayello, Carmella Van de Ven, Mona Elmacken, Anthony Sabulski, Matthew J. Barth, Myron S. Czuczman, Humayun Islam, Christian Klein, Mitchell S. Cairo, Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20(+) rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic leukaemia (pre-B-ALL): potential targeted therapy in patients with poor risk CD20(+) BL and pre-B-ALL. British Journal of Haematology. ,vol. 171, pp. 763- 775 ,(2015) , 10.1111/BJH.13764
Catherine M Bollard, Stephen Gottschalk, Ann M Leen, Heidi Weiss, Karin C Straathof, George Carrum, Mariam Khalil, Meng-fen Wu, M Helen Huls, Chung-Che Chang, M Victoria Gresik, Adrian P Gee, Malcolm K Brenner, Cliona M Rooney, Helen E Heslop, None, Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood. ,vol. 110, pp. 2838- 2845 ,(2007) , 10.1182/BLOOD-2007-05-091280
Alice Pievani, Camilla Belussi, Christian Klein, Alessandro Rambaldi, Josée Golay, Martino Introna, Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies Blood. ,vol. 117, pp. 510- 518 ,(2010) , 10.1182/BLOOD-2010-06-290858
Andrea Borgerding, Justin Hasenkamp, Michael Engelke, Nina Burkhart, Lorenz Trümper, Jürgen Wienands, Bertram Glass, B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression. Experimental Hematology. ,vol. 38, pp. 213- 221 ,(2010) , 10.1016/J.EXPHEM.2009.12.007
Michael R. Verneris, Maki Ito, Jeanette Baker, Arash Arshi, Robert S. Negrin, Judith A. Shizuru, Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma. Biology of Blood and Marrow Transplantation. ,vol. 7, pp. 532- 542 ,(2001) , 10.1016/S1083-8791(01)70014-6
Helen E Heslop, Karen S Slobod, Martin A Pule, Gregory A Hale, Alexandra Rousseau, Colton A Smith, Catherine M Bollard, Hao Liu, Meng-Fen Wu, Richard J Rochester, Persis J Amrolia, Julia L Hurwitz, Malcolm K Brenner, Cliona M Rooney, None, Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients Blood. ,vol. 115, pp. 925- 935 ,(2010) , 10.1182/BLOOD-2009-08-239186